Overview

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

Status:
Unknown status

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether combined chemotherapy [rituximab plus high dosage methotrexate, lomustine, and procarbazine] followed by maintenance therapy with procarbazine is effective in the treatment of cerebral Non Hodgkin lymphoma [PCNSL] in patients > 65 years.

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital Freiburg

Collaborators:

Ludwig-Maximilians - University of Munich
Universitätsklinikum Köln
University Hospital Heidelberg
University Hospital Ulm

Treatments:

Lomustine
Methotrexate
Procarbazine
Rituximab